Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02176148 · ClinicalTrials.gov registry record
Cutaneous Lupus Medication Experience Study
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 11
- Enrollment target
NCT02176148: Completed study, sponsored by Wake Forest University Health Sciences.
NCT02176148 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02176148 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Cutaneous lupus is a chronic, relapsing, auto-immune skin disease that can have many presentations. Its effect on physical appearance greatly affects patients' quality of life. In addition, 10% of patients with cutaneous lupus will develop systemic lupus. Topical therapies are the mainstay of cutaneous lupus treatment; however patients often find these treatments to be messy, inconvenient, or ineffective. In addition, for more severe disease patients are often placed on concurrent systemic therapies. The primary hypothesis of our study is that poor adherence contributes to poor treatment outcomes in patients with cutaneous lupus.
Primary Outcome
There will be interim measures taken after the baseline measure at month 1, month 3, and at end point month 6.
Interventions
- DRUG fluocinonide 0.05% cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-12-04 |
What the finished NCT02176148 record still lists
NCT02176148 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which fluocinonide 0.05% cream is the first listed.
NCT02176148 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02176148 about?
NCT02176148 is a clinical study titled "Cutaneous Lupus Medication Experience Study". Cutaneous lupus is a chronic, relapsing, auto-immune skin disease that can have many presentations. Its effect on physical appearance greatly affects patients' quality of life. In addition, 10% of patients with cutaneous lupus will develop systemic lupus. Topical therapies are the mainstay of cutane...
What is the current status of trial NCT02176148?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2014-12. Estimated completion is 2020-12-04.
What interventions are being tested in trial NCT02176148?
The interventions under investigation include: fluocinonide 0.05% cream (DRUG).
Who is sponsoring clinical trial NCT02176148?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia